{"id":26885,"date":"2021-03-04T14:15:39","date_gmt":"2021-03-04T08:45:39","guid":{"rendered":"https:\/\/corpbiz.io\/learning\/?p=26885"},"modified":"2021-03-04T14:15:42","modified_gmt":"2021-03-04T08:45:42","slug":"cdsco-on-covid-19-on-new-approval-import-safety-measures","status":"publish","type":"post","link":"https:\/\/corpbiz.io\/learning\/cdsco-on-covid-19-on-new-approval-import-safety-measures\/","title":{"rendered":"CDSCO Responds to COVID-19 with New Approval, Import, & Safety Measures"},"content":{"rendered":"\n

The national regulatory body under Ministry of Health and Family Welfare for\u00a0pharmaceuticals\u00a0and\u00a0medical devices\u00a0in India\u00a0is the Central Drugs Standard Control Organisation\u00a0(CDSCO). Since the outbreak of Covid -19 pandemic the Central Drugs Standard Control Organisation (CDSCO) on covid- 19 had released numerous notices since mid of March in order to address the pandemic. CDSCO on covid-19 response has come up with new approval and import regulations and other safety measures.<\/p>\n\n\n\n

The purpose of the CDSCO is to address these new measures to accelerate the access to devices that are intended to treat or prevent the spread of corona virus and to safeguard the supply of other essentials like In-Vitro Diagnostic (IVDs), use of drug license<\/strong><\/a> and also to lessen the exposure of the staffs of CDSCO to the SARS-CoV-2 virus.<\/p>\n\n\n\n

CDSCO on Covid-19 Response to New Approval and Safety\nMeasures<\/h3>\n\n\n\n

There are numbers of responses made by the CDSCO on the new approval and safety measures, which are as follows:-<\/strong><\/em><\/p>\n\n\n\n

\"CDSCO<\/figure><\/div>\n\n\n\n

Emergency\nUtilisation of \u2018remdesivir\u2019<\/h3>\n\n\n\n

The CDSCO on COVID-19 has responded\nwith the outbreak of the pandemic and has granted consent for the emergency\nutilisation of remdesivir to treat patients of novel Coronavirus disease (COVID-19).\n<\/p>\n\n\n\n

Notwithstanding, the Union Ministry of\nHealth and Family Welfare (MoHFW), in a meeting on June 2, 2020, couldn’t share\nthe evidence or the proof based on which this approval was conceded.<\/p>\n\n\n\n

COVID-19\nIVD Test Kits <\/h3>\n\n\n\n

The CDSCO on Covid-19 has announced that it will prioritize the use of COVID-19 IVD test kits for expediting approval on the outbreak of pandemic. <\/p>\n\n\n\n

Read our article<\/b>:How to Obtain Drug License in India?<\/a><\/mark><\/p>\n\n\n\n

Manufacturers\nseek supervision from DCGI<\/h3>\n\n\n\n

Manufacturers of the market are also\nencouraged to talk to the Drugs Controller General of India (DCGI) as they have\nalready got the consent for an IVD and this discussion can result in getting\nfast-track approval.  <\/p>\n\n\n\n

Furthermore, these manufacturers who\nare working for the improvement of new IVDs may make contact with the DCGI\ndirectly to request for supervision on the appropriate regulatory pathway in\naccordance with the guidelines of CDSCO on covid-19.<\/p>\n\n\n\n

CDSCO\non Regulatory Approval Process<\/h3>\n\n\n\n

An additional notice as has been\npublished by the CDSCO that contains all the information and the decision to expedite\nthe approval of the regulatory process for vaccines, prophylactics,\ndiagnostics, and the therapeutics that is designed to prevent or treat the\nCOVID-19 pandemic.\u200b As part of this programme,\nthe CDSCO on covid-19 is creating an enthusiastic corona virus unit to deal\nwith the inquiries on the development and improvement of these products.<\/p>\n\n\n\n

CDSCO\non COVID-19 Vaccine<\/h3>\n\n\n\n

As part of the program for speedy\nresponse to handle COVID-19 regulatory framework there shall be covid-19 vaccines,\nand the CDSCO of India states that it is in a view point to consider the data\ngenerated outside the country and to otherwise development to cut short the\ntime it takes to access the vaccine.<\/p>\n\n\n\n

In accordance with the rules, only\nafter obtaining the undertaking from the importers the import of such drugs may\nbe permitted by the port officers of CDSCO and that they have to ensure that the\ndrug shall be consumed before the expiry date and no part of the drug shall be\naccessible for distribution and sale after its expiry date. This was informed by\nthe CDSCO by a circular issued to all port offices.<\/p>\n\n\n\n

The health ministry has instructed to\ntake various steps and the India\u2019s CDSCO on COVID-19 outbreak has responded to\nthe pandemic accordingly, to make sure the accessibility of an adequate\nquantity of drugs in the domestic market. Moreover, it is important of the\nCDSCO to confirm that the products and drugs are complying with the prescribed\nspecification. The Drug Controller General of India (DCGI) has stated that one\nof the major steps is to immediately issue approvals to the registration\napplications and the process of manufacture and import of pharma.<\/p>\n\n\n\n

CDSCO\n0n COVID-19 and Release of Critical Imported IVDs<\/h3>\n\n\n\n

The CDSCO on covid-19 has issued procedures for temporary modified release and for other critical imported IVDs which shall also include the HIV<\/em><\/strong>[1]<\/em><\/strong><\/a><\/sup> and HBsAG test kits that are required to be followed all through the duration of the COVID-19 pandemic which has lead to cause interruption in the testing and sampling processes.<\/p>\n\n\n\n

The\nCDSCO on covid-19 pandemic has advised the port offices that hold the\nconsignments of the IVDs to only discharge them on the basis of reviewing of the\ndocuments, protocols, the manufacturer\u2019s certification of release, and the\ncompliance history. Nevertheless, it is necessary for the importers to preserve\na “sufficient amount\u201d of IVDs for future examination and to make an assurance\nto call back all the products that fails the laboratory tests in future.<\/p>\n\n\n\n

Two notices\nwere issued by the CDSCO on covid-19 in April 2020 for medical devices and\ndrugs correspondingly, which stated that an applicant for import registration may\nsubmit his applications together with the required documents which should be\nself-attested and with an undertaking that they shall submit the notarized or\nthe apostilled documents once the corona situation becomes normal. <\/p>\n\n\n\n

The\nCDSCO shall on such condition process the application and if satisfied with the\ncompliance of requirements can also issue the licenses with the prior condition\nfor the applicant to submit the notarized or apostilled documents with time.<\/p>\n\n\n\n

Disease Prevention Policies for CDSCO Employees on covid-19<\/h2>\n\n\n\n